Ceva Animal Health extends its anti-parasitic range with the launch of Duoflect

30 April 2018, at 12:48pm

Ceva Animal Health has launched Duoflect, a new strength formulation for the treatment and prevention of flea and tick infestations in cats and dogs, and the environment.

Containing a new strength formulation of fipronil and (s)-methoprene, Duoflect’s duration of action against fleas is 100 percent longer in cats (eight weeks) and 13 percent longer in dogs (nine weeks) than the market-leading fipronil combination, while its duration of action against ticks is 150 percent longer in cats (five weeks) and 50 percent longer in dogs (six weeks). It acts against adult fleas on the animal and immature flea stages in the environment and can be used as part of a treatment strategy for the control of flea allergy dermatitis.

Duoflect is available in new, easy-to-use, free-standing pipettes for easier administration and handling of the pet. The product is competitively priced and is available in boxes of three or six pipettes and in five presentations: small cats (1-5kg), large cats (>5kg) and small dogs (2-10kg), medium dogs (10-20kg), large dogs (20-40kg) and extra-large dogs (40-60kg). It is suitable for cats and dogs from eight weeks of age.